Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05540015
Other study ID # 6482963527
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date December 2022
Est. completion date August 2025

Study information

Verified date September 2022
Source I.M. Sechenov First Moscow State Medical University
Contact Svetlana Tarasenko
Phone +7-985-773-48-53
Email tarasenko_s_v@staff.sechenov.ru
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A comparative analysis of the effectiveness of the erbium laser with the wavelength of 2.94 µm and traditional instruments in the extraction of the impacted lower third molars will be performed. Clinical, radiological and biochemical findings will be assessed after extraction of the impacted lower third molars.


Description:

A single-centre, interventional, non-randomized, prospective clinical trial in 2 parallel groups is planned. The lower third molars will be extracted in 60 patients. There will be 2 groups. The number of men and women in both groups will be the same, the patients age will be between 18 and 70 years. In the study group the lower third molars will be extracted using erbium laser with a wavelength of 2.94 µm (Erbium laser Smart 2940D plus with the wavelength 2,94 µm, company- DEKA, Italy, registration № 2005/1245), in the control group the lower third molars will be extracted using the conventional method (cutting and rotating instruments). Postoperative clinical symptoms such as collateral soft tissue swelling, postoperative pain, trismus in the extraction site and healing time (epithelization and bone regeneration) will be assessed. The epithelization will be assessed after 7, 10, 14 days. The bone regeneration will be assessed by cone beam computed tomography (KAVO, ORTHOPANTOMOGRAPH ОР 3D, type: РСХ-1; registration № РЗН 2020/10586) after 1, 3, 6 months. The radiation exposure will not exceed the permissible limits. Biochemical indicators in the saliva will be assessed before extraction, after extraction, 3 days and 7 days after the extraction. The Shapiro-Wilk test will be applied to check the normality of variable distribu- tion. Qualitative variables will be analyzed by Pearson's chi-squared test. Quantitative variables (normal distribution of variable) will be analyzed by Students t-test, non-normal distribution of variables will be analyzed by Mann-Whitney U test.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 60
Est. completion date August 2025
Est. primary completion date August 2024
Accepts healthy volunteers No
Gender All
Age group 25 Years to 70 Years
Eligibility Inclusion Criteria: 1. Signing of written informed consent of the patient to participate in a study 2. Age from 25 to 50 years old 3. Indications for impacted third molar extraction 4. Patients who are medically stable 5. Therapeutic and surgical oral hygiene before surgery (absence of inflammatory diseases, caries, pulpitis, periodontitis in oral cavity) Exclusion Criteria: 1. Refusal of the patient from further participation in the study 2. Pregnancy diagnosed after the inclusion into the trial 3. Non-compliance by the patient with postoperative recommendations 4. Absence of a lower second molar

Study Design


Intervention

Procedure:
Third molar extraction by cutting and rotary tools
Extraction of the impacted lower third molar will be conducted using cutting and rotary tools under the local anesthesia (Ultracain D-S 1:100000 40 mg/ml, active substance- articaine+epinephrine, registration ? ? N015119/01 ). Scalpel will be used for the incision of the soft tissues, rotary instruments will be used for the bone tissue and tooth fragmentation. After the extraction the wound will be sutured by the suture material.
Third molar extraction by erbium laser with wavelength 2.94 nm
Extraction of the impacted lower third molar will be conducted using erbium laser with wavelength 2.94 nm under the local anesthesia (Ultracain D-S 1:100000 40 mg/ml, active substance- articaine+epinephrine, registration ? ? N015119/01 ). The soft tissue and bone tissue will be dissected by erbium laser with wavelength 2.94 µm (Erbium laser Smart 2940D plus with the wavelength 2,94 µm, company- DEKA, Italy, registration ? 2005/1245). After the extraction the wound will be sutured by the suture material (registration ? ??? 2010/06040; 07.08.2018)

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
I.M. Sechenov First Moscow State Medical University

Outcome

Type Measure Description Time frame Safety issue
Primary Assessment the level of bone regeneration according to Radiographic bone height (RBH) Assessment the level of bone regeneration according to Radiographic bone height (RBH) by cone beam computed tomography after extraction of the lower third molar. (Radiographic bone height (RBH)- is the distance between root apex of the distal root and uppermost intersecting point between distal root of the second molar and mesial wall of extraction socket, it will be measured on the cone beam computed tomography) Days 180 after extraction
Secondary Radiographic bone height (RBH) Assessment the level of bone regeneration according to Radiographic bone height (RBH) by cone beam computed tomography after extraction of the lower third molar with erbium laser. (Radiographic bone height (RBH)- is the distance between root apex of the distal root of the second molar and uppermost intersecting point between distal root of the second molar and mesial wall of extraction socket, it will be measured on the cone beam computed tomography) 3;6 months
Secondary Radiographic infrabony defect (RID) Assessment the level of bone regeneration according to Radiographic infrabony defect (RID) by cone beam computed tomography after extraction of the lower third molar with erbium laser. (Radiographic infrabony defect (RID) is the distance between cemento-enamel junction of the second molar and uppermost intersecting point between distal root of the second molar and mesial wall of extraction socket; it will be measured on the cone beam computed tomography) 3;6 months
Secondary Post-operative pain Post-operative pain will be assessed by 10-point visual analogue scale (VAS) in the area of the extracted tooth 1;3;5;7;10 days
Secondary Post-operative oedema Assessment the soft tissue epithelization using six-point Visual Analogue Scale (VAS) of swelling, where 0 indicates "no swelling", and 5 indicates "extreme severe swelling 1;3;5;7;10 days
Secondary Soft tissue epithelization Assessment the soft tissue epithelization using a photoprotocol (the day on which full tissue regeneration has taken place will be taken into account) 7;10;14
Secondary Trismus Assessment the distance between upper and lower incisors in mm 1;3;5;7;10 days
Secondary sRANKL (soluble receptor activator of nuclear factor-?B ligand) Assessment the level of sRANKL in saliva by enzyme-linked immunosorbent assay, ELISA before surgery, after surgery, 3;7 days
Secondary OPG (osteoprotegerin) Assessment the level of OPG in saliva by enzyme-linked immunosorbent assay, ELISA before surgery, after surgery, 3;7 days
Secondary Fibroblast growth factor-b (FGF-b) Assessment the level of FGF-b in saliva before surgery, after surgery, 3;7 days
Secondary C-reactive protein (CRP) Assessment the level of CRP in saliva by enzyme-linked immunosorbent assay before surgery, after surgery, 3;7 days
Secondary IgA Assessment the level of IgA in saliva by enzyme-linked immunosorbent assay before surgery, after surgery, 3;7 days
Secondary IgG Assessment the level of IgG in saliva by enzyme-linked immunosorbent assay before surgery, after surgery, 3;7 days
Secondary IgM Assessment the level of IgM in saliva by enzyme-linked immunosorbent assay before surgery, after surgery, 3;7 days
Secondary Vascular endothelial growth factor (VEGF) Assessment the level of VEGF in saliva by enzyme-linked immunosorbent assay before surgery, after surgery, 3;7 days
See also
  Status Clinical Trial Phase
Completed NCT06023524 - The Effectiveness of Laser Acupuncture and Standard Medication Therapy on Mandibular Post-Odontectomy Patients N/A
Completed NCT02547896 - Effectiveness of Diclofenac and Its Association to Codeine After Lower Third Molar Extraction. Phase 4
Completed NCT05684601 - Impact of 3D Intraoral Scanning on Postsurgical Evaluation of Mandibular Third Molar Surgery N/A
Completed NCT05170516 - The Effect of Saline Irrigation at Different Temperatures on Pain, Edema, and Trismus After Impacted Third Molar Surgery N/A
Completed NCT02481700 - Epidemiological Study on the Surgical Removal of Third Molars
Completed NCT05488028 - 3D Evaluation of Facial Swelling Post Impacted Lower Third Molars Surgery: RCT N/A
Completed NCT05679973 - Evaluation of the Efficacy of Polybutester Suture on Postoperative Complications in Lower Impacted Third Molar Surgery N/A
Recruiting NCT03741894 - Examination of the Prevention and Treatment Modalities of Alveolitis in Relation With Impacted Teeth Surgery Phase 4
Completed NCT06017570 - Risk Factors for Distal Caries of Second Molars Adjacent to Mandibular Impacted Third Molars N/A
Completed NCT03894722 - Effects of Polyvinylpyrrolidone Iodine on Postoperative Trismus and Swelling During Impacted Third Molar Surgery Phase 4
Completed NCT02837614 - Evaluation of Preoperative Submucosal Dexamethasone in Third Molar Surgery Phase 0
Completed NCT02831374 - Effectiveness of Platelet Rich Plasma in Wound Healing Phase 0
Completed NCT02494856 - Comparison of the Clinical Efficacy of Naproxen, Associated or Not With Esomeprazol, in Lower Third Molar Removal Phase 4
Completed NCT02450487 - Influence of Genotype of CYP2C9 on Clinical Efficacy and Pharmacokinetics of Piroxicam After Lower Third Molar Surgery Phase 4
Completed NCT05545553 - Piezosurgery and Conventional Rotary Instruments on Third Molar Surgery N/A
Recruiting NCT03619460 - Clinical Efficacy of a New Piezoelectric Technique for Wisdom Teeth Extraction N/A
Not yet recruiting NCT05143359 - Accuracy of Variables for Impacted Mandibular Third Molar Surgery N/A
Completed NCT03784638 - Comparison of Two Different Flap Designs for Bilateral Impacted Mandibular Third Molar Surgery N/A
Completed NCT03752255 - Verbal and Visual Information Techniques on Anxiety in Third Molar Surgery N/A
Active, not recruiting NCT04349579 - Evaluation of the Effects of Irrigation of the Extraction Socket With Rifamycine Phase 4